NCT00153673View on ClinicalTrials.gov

Effect of Selective COX-2 Inhibition on Ulcer Healing

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

December 28, 2016

Study Completion Date

April 12, 2017

Conditions
ArthritisGastric Ulcer
Interventions
DRUG

celecoxib

Celecoxib 200mg bd

DRUG

Dologesics

Dologesics 2 tablets bd

Trial Locations (1)

Unknown

Endoscopy Center, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00153673 - Effect of Selective COX-2 Inhibition on Ulcer Healing | Biotech Hunter | Biotech Hunter